Gara Jalqabaatti › Neuroblastoma › Pennsylvania
Qorannoo klinikaalii Neuroblastoma Pennsylvania keessatti
Qorannoo 14 Neuroblastoma f Pennsylvania keessatti hirmaatuu jiru.
Magaalota Pennsylvania keessatti
Takkalaa qorannoo (Ingiliffa)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Children's Hospital of Philadelphia, Philadelphia
- fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Hanga umuriin 30 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
Namoota walitti qabaa jiraSadarkaa 1/2
6 Months – 25 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06395103Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 22 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 26 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 30 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06541262Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Children's Hospital, Hershey
- fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
365 Days – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Namoota walitti qabaa jiraSadarkaa 2
12 Months – 21 Years · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT05489887SPEARHEAD-3 Pediatric Study
- Children's Hospital of Philedephia, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 2 hanga 21 · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05642455PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Children's Hospital of Philadelphia, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06721689NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Children's Hospital of Philadelphia, Philadelphia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 31 · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT06450041Neuroblastoma Biology Study
- Children's Hospital of Philadelphia, Philadelphia
Namoota walitti qabaa jiraQorannoo ilaalaa
31 Days – 99 Years · Saalaa hunda · Haaromfame 23-Bit-2026 · NCT01587300Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Children's Hospital of Philadelphia, Philadelphia
Namoota walitti qabaa jira
Hanga umuriin 17 · Saalaa hunda · Haaromfame 10-Gur-2026 · NCT06831552Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.